| CDS Tool Information - A1c Target Individualization | |
|---|---|
| Intended Purpose(s) | Used to determine optimal glycemic targets |
| Indicated in patients with | Diabetes |
| Indicated in ff. interventions | NA |
| Predicted Outcomes | NA |
| Prediction Period | NA |
| Caution(s) | NA |
| Mathematical Formula |
Person and disease factors used to determine optimal glycemic targets
Characteristics and predicaments toward the left justifymore stringent efforts to lower A1C; those toward the right suggest less stringent efforts. A1C 7% = 53 mmol/mol. Adapted with permission from Inzucchi et al. (36). |
| Additional Explanations |
NA |
| Interpretation |
NA |
| Recommendations |
NA |
| Original Reference |
American Diabetes Association Professional Practice Committee. "6. Glycemic goals and hypoglycemia: Standards of Care in Diabetes— 2024.", Diabetes Care, vol. 47, Suppl. 1, pp. S111–S125. https://doi.org/10.2337/dc24-S006 |
| Validation Reference(s) |
NA |
| Other Reference(s) |
Inzucchi SE, Bergenstal RM, Buse JB, et al., 'Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.', Diabetes Care, vol. 38, pp. 140–149. |
| Abbreviation Text |
NA |
| Footnote Text |
A1C 7% = 53 mmol/mol. Adapted with permission from Inzucchi et al. (36). |
